{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T06:27:31Z","timestamp":1749018451526,"version":"3.32.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>To demonstrate the challenges with current diagnosis and treatment strategies for precipitated opioid withdrawal secondary to naloxone the emergency department (ED) setting and describe the role of the emergency medicine (EM) pharmacist in its management.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>There are no standardized criteria to define precipitated opioid withdrawal syndrome, so the diagnosis is typically based on sentinel signs and symptoms and time course. Complicating factors include a positive urine toxicology screen for nonopioid substances, comorbidities and associated medications prior to admission, medications given in the ED, and a fluctuating patient course during the ED stay that likely involves all these issues. Although buprenorphine is frequently recommended as the primary treatment for precipitated withdrawal, its use can be complicated if patients are on methadone maintenance or other long-acting opioids. The EM pharmacist plays a key role in managing patients with precipitated withdrawal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Practice changes related to the diagnosis and treatment of opioid use disorder (OUD) with precipitated withdrawal in the ED are needed. EM pharmacists as part of the interprofessional care team have an important role in the management of patients with OUD, including those patients undergoing possible precipitated withdrawal.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxae212","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T16:26:00Z","timestamp":1721406360000},"page":"60-64","source":"Crossref","is-referenced-by-count":1,"title":["Challenges with current diagnosis and treatment strategies for precipitated opioid withdrawal in the emergency department and the role of the pharmacist"],"prefix":"10.1093","volume":"82","author":[{"given":"Melody J","family":"Glenn","sequence":"first","affiliation":[{"name":"Departments of Emergency Medicine and Psychiatry, University of Arizona College of Medicine\/Banner University Medical Center , Tucson, AZ ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L","family":"Erstad","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy , Tucson, AZ ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"author":"Centers for Disease Control and Prevention","key":"2025010605553486500_CIT0001"},{"key":"2025010605553486500_CIT0002","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajem.2022.05.013","article-title":"Buprenorphine precipitated opioid withdrawal: prevention and management in the ED setting","volume":"58","author":"Spadaro","year":"2022","journal-title":"Am J Emerg Med"},{"key":"2025010605553486500_CIT0003","doi-asserted-by":"publisher","first-page":"1141980","DOI":"10.3389\/fpsyt.2023.1141980","article-title":"Operational definition of precipitated opioid withdrawal","volume":"14","author":"Dunn","year":"2023","journal-title":"Front Psychiatry"},{"issue":"1","key":"2025010605553486500_CIT0004","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/20009666.2020.1854417","article-title":"Naloxone induced pulmonary edema","volume":"11","author":"Elkattawy","year":"2021","journal-title":"J Community Hosp Intern Med Perspect"},{"year":"2021","author":"CA Bridge","key":"2025010605553486500_CIT0005"},{"issue":"4","key":"2025010605553486500_CIT0006","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/ADM.0000000000000929","article-title":"Synergistic effect of ketamine and buprenorphine observed in the treatment of buprenorphine precipitated opioid withdrawal in a patient with fentanyl use","volume":"16","author":"Hailozian","year":"2022","journal-title":"J Addict Med"},{"issue":"3","key":"2025010605553486500_CIT0007","doi-asserted-by":"publisher","first-page":"691.e3","DOI":"10.1016\/j.ajem.2019.09.014","article-title":"Treatment of acute naloxone-precipitated opioid withdrawal with buprenorphine","volume":"38","author":"Chhabra","year":"2020","journal-title":"Am J Emerg Med"},{"key":"2025010605553486500_CIT0008","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.120821.1","article-title":"Case report: buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine [version 1; peer review: awaiting peer review]","author":"Bormann","year":"2022","journal-title":"F1000Res"},{"issue":"1","key":"2025010605553486500_CIT0009","doi-asserted-by":"publisher","first-page":"e12680","DOI":"10.1111\/adb.12680","article-title":"Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes","volume":"25","author":"Dunn","year":"2020","journal-title":"Addict Biol"},{"issue":"1","key":"2025010605553486500_CIT0010","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the U.S. opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Mol Psychiatry"},{"key":"2025010605553486500_CIT0011","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.2147\/JPR.S295715","article-title":"The polysubstance overdose-death crisis","volume":"13","author":"Peppin","year":"2020","journal-title":"J Pain Res"},{"issue":"2","key":"2025010605553486500_CIT0012","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: a broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"Am J Public Health"},{"issue":"18","key":"2025010605553486500_CIT0013","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMp2308525","article-title":"Scaling up point-of-care fentanyl testing \u2014 a step forward","volume":"389","author":"Barnett","year":"2023","journal-title":"N Engl J Med"},{"year":"2023","key":"2025010605553486500_CIT0014"},{"issue":"1","key":"2025010605553486500_CIT0015","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s13181-023-00981-z","article-title":"American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time","volume":"20","author":"Stolbach","year":"2024","journal-title":"J Med Toxicol"},{"issue":"7","key":"2025010605553486500_CIT0016","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2025010605553486500_CIT0017","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13011-019-0195-4","article-title":"Higher doses of naloxone are needed in the synthetic opioid era","volume":"14","author":"Moss","year":"2019","journal-title":"Subst Abuse Treat Prev Policy"},{"year":"2022","key":"2025010605553486500_CIT0018"},{"issue":"2","key":"2025010605553486500_CIT0019","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N Engl J Med"},{"key":"2025010605553486500_CIT0020","doi-asserted-by":"publisher","first-page":"103457","DOI":"10.1016\/j.drugpo.2021.103457","article-title":"Increasingly powerful opioid antagonists are not necessary","volume":"99","author":"Hill","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"3","key":"2025010605553486500_CIT0021","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1016\/j.jemermed.2023.05.006","article-title":"Systematic review of naloxone dosing and adverse events in the emergency department","volume":"65","author":"Yugar","year":"2023","journal-title":"J Emerg Med"},{"issue":"5","key":"2025010605553486500_CIT0022","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/emp2.12138","article-title":"Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best Practices in the Evaluation and Treatment of Agitation)","volume":"1","author":"Roppolo","year":"2020","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"2025010605553486500_CIT0023","doi-asserted-by":"publisher","first-page":"S0736","DOI":"10.1016\/j.jemermed.2022.01.009","article-title":"Efficacy of combination haloperidol, lorazepam, and diphenhydramine vs. combination haloperidol and lorazepam in the treatment of acute agitation: a multicenter retrospective cohort study","author":"Jeffers","year":"2022","journal-title":"J Emerg Med"},{"issue":"4","key":"2025010605553486500_CIT0024","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/ADM.0000000000001151","article-title":"Precipitated opioid withdrawal treated with ketamine in a hospitalized patient: a case report","volume":"17","author":"Christian","year":"2023","journal-title":"J Addict Med"},{"issue":"4","key":"2025010605553486500_CIT0025","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/ADM.0000000000000929","article-title":"Synergistic effect of ketamine and buprenorphine observed in the treatment of buprenorphine precipitated opioid withdrawal in a patient with fentanyl use","volume":"16","author":"Luftig","year":"2022","journal-title":"J Addict Med"},{"issue":"6","key":"2025010605553486500_CIT0026","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/ajhp\/zxad289","article-title":"Considerations and limitations of buprenorphine prescribing for opioid use disorder in the intensive care unit setting: a narrative review","volume":"81","author":"Erstad","year":"2024","journal-title":"Am J Health-Syst Pharm"},{"issue":"1","key":"2025010605553486500_CIT0027","doi-asserted-by":"publisher","first-page":"e12880","DOI":"10.1002\/emp2.12880","article-title":"Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: a case series","volume":"4","author":"Spadaro","year":"2023","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"7","key":"2025010605553486500_CIT0028","doi-asserted-by":"publisher","first-page":"e2117128","DOI":"10.1001\/jamanetworkopen.2021.17128","article-title":"High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder","volume":"4","author":"Herring","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2025010605553486500_CIT0029","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.1503\/cmaj.74018","article-title":"Buprenorphine-naloxone \u201cmicrodosing\u201d: an alternative induction approach for the treatment of opioid use disorder in the wake of North America\u2019s increasingly potent illicit drug market","volume":"192","author":"Randhawa","year":"2020","journal-title":"CMAJ"},{"issue":"4","key":"2025010605553486500_CIT0030","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/ajad.13135","article-title":"Microinduction of buprenorphine\/naloxone: a review of the literature","volume":"30","author":"Ahmed","year":"2021","journal-title":"Am J Addict"},{"issue":"5","key":"2025010605553486500_CIT0031","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40261-021-01032-7","article-title":"The pharmacology of buprenorphine microinduction for opioid use disorder","volume":"41","author":"De Aquino","year":"2021","journal-title":"Clin Drug Investig"},{"author":"CA Bridge","key":"2025010605553486500_CIT0032"},{"year":"2022","key":"2025010605553486500_CIT0033"},{"issue":"6","key":"2025010605553486500_CIT0034","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jcpt.12196","article-title":"The clinical analgesic efficacy of buprenorphine","volume":"39","author":"Raffa","year":"2014","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"2025010605553486500_CIT0035","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1186\/s13063-018-3055-z","article-title":"Single high-dose buprenorphine for opioid craving during withdrawal","volume":"19","author":"Ahmadi","year":"2018","journal-title":"Trials"},{"issue":"5","key":"2025010605553486500_CIT0036","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1521-0391.2012.00262.x","article-title":"Treatment of buprenorphine precipitated withdrawal: a case report","volume":"21","author":"Jutras-Aswad","year":"2012","journal-title":"Am J Addict"},{"key":"2025010605553486500_CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.10.024","article-title":"Management of critically ill patients receiving medications for opioid use disorder","author":"Erstad","year":"2023","journal-title":"Chest"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxae212\/58697970\/zxae212.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/2\/60\/58697970\/zxae212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/2\/60\/58697970\/zxae212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:55:43Z","timestamp":1736142943000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/82\/2\/60\/7717129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,7,19]]},"published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxae212","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"type":"print","value":"1079-2082"},{"type":"electronic","value":"1535-2900"}],"subject":[],"published-other":{"date-parts":[[2025,1,15]]},"published":{"date-parts":[[2024,7,19]]}}}